Merck KGaA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
MKKGY Over the counter 2836 www.emdgroup.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Merck KGaA

[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - Aug 6th, 2026 3:30 pm
Merck KGaA (MKGAF) (Q2 2026) Earnings Call Highlights: Robust Growth and Raised Guidance Signal ... - Aug 6th, 2026 1:04 pm
Merck KGaA Q2 Earnings Call Highlights - Aug 6th, 2026 8:04 am
Merck KGaA (MKKGY) Misses Q2 Earnings Estimates - Aug 6th, 2026 5:10 am
Merck KGaA Q2 adjusted profit rises 9%, hikes FY outlook - Aug 6th, 2026 12:01 am
[Latest] Global Deep Eutectic Solvents Market Size/Share Worth USD 735.89 Million by 2034 at a 15.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - Aug 5th, 2026 1:30 pm
Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development - Jul 29th, 2026 2:00 am
Merck KGaA (MKKGY) Moves to Strong Buy: Rationale Behind the Upgrade - Jul 23rd, 2026 10:00 am
Should Value Investors Buy Merck KGaA (MKKGY) Stock? - Jul 23rd, 2026 7:40 am
Merck KGaA (XTRA:MRK) Opens New Darmstadt Testing Site As Pipeline Progress Builds - Jul 18th, 2026 3:07 am
MilliporeSigma Announces Opening of BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe - Jul 16th, 2026 6:11 am
Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last? - Jul 16th, 2026 2:53 am
Cell Isolation Market/Cell Separation Market by Product, Cell Type, Source, Technique, Application, End User, Competition, Region - Global Forecast to 2031 - Jul 13th, 2026 2:31 am
EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations - Jul 8th, 2026 6:00 am
Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor - Jul 8th, 2026 4:30 am
Merck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline - Jul 7th, 2026 9:31 am
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now? - Jul 7th, 2026 7:40 am
Cyllene Therapeutics Raises €33 Million Series C - Jul 7th, 2026 6:15 am
The $11 Billion Reason TECH Stock Is Up Today - Jun 26th, 2026 11:28 am
Merck KGaA to acquire Bio-Techne in $11.3 billion deal - Jun 26th, 2026 8:13 am